Both in Pharmaceuticals
Nkarta vs ALX Oncology Holdings
Over the past year NKTX returned +26.6% and ALXO returned −22.9%; their daily moves had a correlation of 0.27.
NKTX +26.6% ALXO −22.9%Growth of $1, one year, split-adjusted
| Metric | NKTX | ALXO |
|---|---|---|
| Price | $2.62 | $1.35 |
| Market cap | $187.7M | $186.7M |
| Today | −1.87% | −2.88% |
| 1 month | −5.1% | −32.5% |
| 6 months | +31.0% | −29.3% |
| Year to date | +41.6% | +19.5% |
| 1 year | +28.4% | −27.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $182.8M | $128.5M |
| Dividend yield | — | — |
| Volatility (60d) | 69.3% | 66.1% |
| Short % of float | 8.3% | 6.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).